A Study in Adult Subjects With Chronic Hepatitis B Infection to Support

See also
Status	Clinical Trial	Phase
Completed	`NCT02415842` - A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
Active, not recruiting	`NCT00959491` - A Prospective Study of a New Immunological Fecal Occult Blood Test	N/A
Completed	`NCT01099488` - A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02415842 - A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Active, not recruiting

NCT00959491 - A Prospective Study of a New Immunological Fecal Occult Blood Test

N/A

Completed

NCT01099488 - A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01098006
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	N/A
Start date	April 29, 2010
Completion date	February 20, 2012

A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms